Fund for Strategic Investment
225 Pictoria Drive, Suite 450, Cincinnati, OH, 45246, United States
Overview
Strategic Investment Fund is a strategic investment arm of the Bill & Melinda Gates Foundation that collaborate with foundation programs to identify investment opportunities in companies.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Non Profit
Investment portfolio
- Abionyx Pharma
Led · Series C · Jul 2010
Abionyx Pharma is a biotech company based in Balma developing therapies to combat sepsis, with its lead investigational candidate CER-001 aimed at treating septic shock. The company has launched an €18.7M capital increase with preferential subscription rights and secured a subscription agreement with Fenja Capital for up to €14M in two tranches. Those financings provide immediate funding of €28.7M and could total €32.7M if the second tranche is exercised. Abionyx says the proceeds will be used to accelerate development of CER-001. No prior funding rounds or operating metrics were disclosed in the article.
Team
No current team members are available.